A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a new study.
The study involved 53 men and women with an average age of 38. The participants were given a combination of several antiretroviral drugs known as Highly Active Anti-Retroviral Therapy (HAART) for one year. Researchers tested the participants’ cerebrospinal fluid before and after treatment to see if there were elevated levels of a particular biomarker for brain injury called neurofilament light protein.
The study found 21 people had high levels of the protein, suggestive of brain damage, at the beginning of treatment. But after three months of taking HAART, those high levels of protein fell to normal levels in nearly half of the patients. After one year of treatment, only four people still had high levels of this particular biomarker for brain damage.
In addition, for the 32 patients who had normal levels of the protein at the beginning of the study, all but one remained normal at follow-up.
“This type of treatment appears to halt the neurodegenerative process caused by HIV,” said study author Åsa Mellgren, MD, PhD, with the Clinic of Infectious Diseases SÄS in Borås, Sweden, and the Sahlgrenska Academy at Göteborg University in Göteborg, Sweden. “This study confirms that neurofilament light protein serves as a useful marker in monitoring brain injury in people with HIV and in evaluating the effectiveness of HAART.”
The study also found nine of the 21 people with high levels of the protein had dementia as a result of AIDS and their levels of the protein were significantly higher than those without dementia at the beginning of the study. “But four of these people with dementia did not see their levels return to normal by the end of the study,” said Mellgren. “It’s possible these levels may have reached normal limits if the study had been longer.”
Mellgren says a larger, longitudinal study of the protein is needed that includes more extensive neurological measures, including cognitive testing of the study participants.
The study was supported by grants from the National Institutes of Health, Göteborg University, and Research Foundation of Swedish Physicians against AIDS.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- How Gut Bacteria Ensure A Healthy Brain – and Could Play A Role In Treating Depression
- Researchers Created A Laser Bullet To See What It Would Look Like - And Here It Is
- The Strange Organic Molecules In Titan's Atmosphere
- We're Too Late To Prevent 137,000 More Ebola Cases, Says Epidemiology Paper
- The Quote Of The Week - Shocked And Disappointed
- Type 1 Diabetes Surges In White Kids
- ASTEROIDS Act: Who Owns Space?
- "Because there are only 2?..."
- "I found the AMO/PDO charts to be very broad, and hard to tell (at least with the limited knowledge..."
- "I have dabbled with AMO and PDO, but it really needs to be more of a comparison to SST's, at which..."
- "The UN with it's small direct Ebola budget is hiring Ebola survivors to take care of sick kids..."
- "Ebola patients are sometimes thought of as Zombies returning from the dead. If one is low in fluids..."
- How to sell a toxic pesticide the smart way–call it organic
- Leftist dystopia? Anti-technology fever animates opposition to GMOs and other ‘disruptive’ technologies
- CDC faced a nearly impossible balancing act with Ebola, and failed
- Why Chobani reversed course, making yoghurt only from milk from cows not fed GMO grain
- Monterey, California, hotbed of anti-GMO activism, home to new GMO corn farm
- Evolution is sometimes messy or even outright ridiculous
- NASA sees Tropical Storm Ana still vigorous
- Startups should seek quality -- not quantity -- in partnerships, study finds
- Satellite catches lingering remnants of Tropical Depression 9
- Li-ion batteries contain toxic halogens, but environmentally friendly alternatives exist
- Volunteer guidelines for clinicians in the ebola epidemic